Kinnevik
Kinnevik AB is a Swedish investment company focused on building digital consumer, healthcare, and software businesses globally. The firm concentrates its growth capital strategy on early-to-growth stage private enterprises in digital health, software-as-a-service, and financial technology across Europe and the US. Key portfolio holdings include equity stakes in companies such as Spring Health, Cityblock, Pleo, and TravelPerk. Revenue and value generation stem from capital gains on equity divestments, unrealized portfolio valuation growth, and investment dividends. Kinnevik holds a market-leading position as a major European growth-focused investment firm. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq Stockholm.
31 of the funds FundTelligence covers report a position in Kinnevik.
- Legal name
- Kinnevik AB
- Sector
- Financials
- Country
- Sweden
- Funds holding it
- 31
Funds holding Kinnevik
- Indecap Guide Q30 — Indecap · 2.99 % (full portfolio disclosed, June 2026)
- Carnegie Spin-Off — Carnegie · 2.2 % (full portfolio disclosed, June 2026)
- Case Högräntefond — Case · 1.4 % (full portfolio disclosed, June 2026)
- Nordea Alfa — Nordea Funds · 1.2 % (full portfolio disclosed, September 2026)
- Aktiespararna Småbolag Edge — Cicero Fonder · 1.18 % (full portfolio disclosed, June 2026)
- Tellus Midas — Tellus · 1.08 % (full portfolio disclosed, June 2026)
- Alfred Berg Nordic Short Term — Alfred Berg · 1.05 % (full portfolio disclosed, June 2026)
- Carnegie Investment Grade — Carnegie · 0.86 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 31 funds holding it.